User profiles for Rob van Binnendijk
 | Rob van BinnendijkVerified email at rivm.nl Cited by 3493 |
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
…, AA van der Eijk, RS van Binnendijk… - Nature …, 2020 - nature.com
The world is entering a new era of the COVID-19 pandemic in which there is an increasing
call for reliable antibody testing. To support decision making on the deployment of serology …
call for reliable antibody testing. To support decision making on the deployment of serology …
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …
…, RSN Fehrmann, RS van Binnendijk… - The Lancet …, 2021 - thelancet.com
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19
…, JA Van Doesum, RS Van Binnendijk… - JAMA …, 2022 - jamanetwork.com
Importance It has become common practice to offer immunocompromised patients with
hematologic cancers a third COVID-19 vaccination dose, but data substantiating this are scarce. …
hematologic cancers a third COVID-19 vaccination dose, but data substantiating this are scarce. …
The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or …
Background. In kidney patients COVID-19 is associated with severely increased morbidity
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine …
…, D van Baarle, R van Binnendijk… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave
…, M van Boven, RS van Binnendijk… - J epidemiol community …, 2021 - jech.bmj.com
Background We aimed to detect SARS-CoV-2 serum antibodies in the general population of
the Netherlands and identify risk factors for seropositivity amidst the first COVID-19 …
the Netherlands and identify risk factors for seropositivity amidst the first COVID-19 …
Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
…, H van Werkhoven, R van Binnendijk… - Nature …, 2023 - nature.com
An increasing proportion of the population has acquired immunity through COVID-19 vaccination
and previous SARS-CoV-2 infection, ie, hybrid immunity, possibly affecting the risk of …
and previous SARS-CoV-2 infection, ie, hybrid immunity, possibly affecting the risk of …
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
…, BI Lissenberg-Witte, RS Van BInnendijk… - Blood …, 2022 - ashpublications.org
Vaccination guidelines for patients treated for hematological diseases are typically conservative.
Given their high risk for severe COVID-19, it is important to identify those patients that …
Given their high risk for severe COVID-19, it is important to identify those patients that …
Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014
…, J Sane, KB Yap, RS van Binnendijk - The Journal of …, 2016 - academic.oup.com
Background We investigated a measles outbreak among healthcare workers (HCWs) by
assessing laboratory characteristics, measles vaccine effectiveness, and serological correlates …
assessing laboratory characteristics, measles vaccine effectiveness, and serological correlates …
Rubella outbreak in the Netherlands, 2004–2005: high burden of congenital infection and spread to Canada
S Hahné, J Macey, R van Binnendijk… - The Pediatric …, 2009 - journals.lww.com
Background: In The Netherlands and Canada the measles, mumps, rubella vaccine coverage
is high. In 2004 a rubella outbreak started in the Netherlands in a population subgroup …
is high. In 2004 a rubella outbreak started in the Netherlands in a population subgroup …
